Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ribose phosphate diphosphokinase activity	PRPS2 PRPS1L1 PRPS1	1.70e-06	5	112	3	GO:0004749
GeneOntologyMolecularFunction	diphosphotransferase activity	PRPS2 PRPS1L1 PRPS1	3.39e-06	6	112	3	GO:0016778
GeneOntologyMolecularFunction	AMP binding	PRPS2 PFKL PFKM PRPS1	5.21e-06	21	112	4	GO:0016208
GeneOntologyMolecularFunction	N-acetyl-L-aspartate-L-glutamate ligase activity	RIMKLA RIMKLB	3.12e-05	2	112	2	GO:0072590
GeneOntologyMolecularFunction	ABC-type polyamine transporter activity	ATP13A2 ATP13A3	3.12e-05	2	112	2	GO:0015417
GeneOntologyMolecularFunction	6-phosphofructokinase activity	PFKL PFKM	9.32e-05	3	112	2	GO:0003872
GeneOntologyMolecularFunction	cell adhesion molecule binding	SPTAN1 OBSCN UNC45A ITGAD JAML SLC3A2 MPRIP POSTN TLN1 TENM1 DIAPH3 CCS	1.37e-04	599	112	12	GO:0050839
GeneOntologyMolecularFunction	phospholipid binding	SESTD1 GAS6 OBSCN ATP13A2 PLEKHA8P1 CADPS SCARB2 TLN1 ARHGAP44 PLEKHA8 RASAL1	2.59e-04	548	112	11	GO:0005543
GeneOntologyMolecularFunction	fructose-6-phosphate binding	PFKL PFKM	3.08e-04	5	112	2	GO:0070095
GeneOntologyMolecularFunction	fructose binding	PFKL PFKM	4.61e-04	6	112	2	GO:0070061
GeneOntologyMolecularFunction	ceramide 1-phosphate binding	PLEKHA8P1 PLEKHA8	6.43e-04	7	112	2	GO:1902387
GeneOntologyMolecularFunction	ceramide 1-phosphate transfer activity	PLEKHA8P1 PLEKHA8	6.43e-04	7	112	2	GO:1902388
GeneOntologyMolecularFunction	phosphofructokinase activity	PFKL PFKM	6.43e-04	7	112	2	GO:0008443
GeneOntologyMolecularFunction	cadherin binding	SPTAN1 OBSCN UNC45A SLC3A2 MPRIP TLN1 DIAPH3 CCS	6.54e-04	339	112	8	GO:0045296
GeneOntologyMolecularFunction	phosphatidylserine binding	SESTD1 GAS6 SCARB2 TLN1	7.58e-04	73	112	4	GO:0001786
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	HJV PRPS2 TUT7 OBSCN PFKL PFKM POLA2 TIPARP PRPS1L1 NEK4 TESK2 PEAK1 MAP2K2 PRPS1	7.66e-04	938	112	14	GO:0016772
GeneOntologyMolecularFunction	ceramide transfer activity	PLEKHA8P1 PLEKHA8	8.54e-04	8	112	2	GO:0120017
GeneOntologyMolecularFunction	phosphatidylinositol-4-phosphate binding	SESTD1 OBSCN PLEKHA8	1.07e-03	36	112	3	GO:0070273
GeneOntologyMolecularFunction	P-type transmembrane transporter activity	ATP13A2 ATP2C2 ATP13A3	1.07e-03	36	112	3	GO:0140358
GeneOntologyMolecularFunction	P-type ion transporter activity	ATP13A2 ATP2C2 ATP13A3	1.07e-03	36	112	3	GO:0015662
GeneOntologyMolecularFunction	sphingolipid transfer activity	PLEKHA8P1 PLEKHA8	1.09e-03	9	112	2	GO:0120016
GeneOntologyMolecularFunction	polyamine transmembrane transporter activity	ATP13A2 ATP13A3	1.66e-03	11	112	2	GO:0015203
GeneOntologyMolecularFunction	protein homodimerization activity	PRPS2 SYNE1 WRN TRIM6 JAML SLC3A2 PDLIM4 PRPS1L1 SCARB2 TENM1 DIAPH3 PRPS1	2.07e-03	815	112	12	GO:0042803
GeneOntologyBiologicalProcess	5-phosphoribose 1-diphosphate metabolic process	PRPS2 PRPS1L1 PRPS1	3.16e-06	6	113	3	GO:0046391
GeneOntologyBiologicalProcess	5-phosphoribose 1-diphosphate biosynthetic process	PRPS2 PRPS1L1 PRPS1	3.16e-06	6	113	3	GO:0006015
GeneOntologyBiologicalProcess	regulation of glucosylceramidase activity	ATP13A2 SCARB2	2.98e-05	2	113	2	GO:1905123
GeneOntologyBiologicalProcess	cellular response to vitamin K	GAS6 POSTN	2.98e-05	2	113	2	GO:0071307
GeneOntologyCellularComponent	ribose phosphate diphosphokinase complex	PRPS2 PRPS1L1 PRPS1	1.57e-06	5	114	3	GO:0002189
GeneOntologyCellularComponent	6-phosphofructokinase complex	PFKL PFKM	8.81e-05	3	114	2	GO:0005945
Domain	PRPP_SYNTHASE	PRPS2 PRPS1L1 PRPS1	2.27e-07	3	115	3	PS00114
Domain	PRib_PP_synth_CS	PRPS2 PRPS1L1 PRPS1	2.27e-07	3	115	3	IPR000842
Domain	Pribosyltran_N	PRPS2 PRPS1L1 PRPS1	2.25e-06	5	115	3	PF13793
Domain	Pribosyl_synth	PRPS2 PRPS1L1 PRPS1	2.25e-06	5	115	3	PF14572
Domain	Rib-P_diPkinase	PRPS2 PRPS1L1 PRPS1	2.25e-06	5	115	3	IPR005946
Domain	Pribosyltran_N	PRPS2 PRPS1L1 PRPS1	2.25e-06	5	115	3	IPR029099
Domain	Pribosyltran	PRPS2 PRPS1L1 PRPS1	3.62e-05	11	115	3	PF00156
Domain	ATP-grasp_RimK-type	RIMKLA RIMKLB	3.76e-05	2	115	2	IPR013651
Domain	ARHGEF5_35	ARHGEF5 ARHGEF35	3.76e-05	2	115	2	PF15441
Domain	ARHGEF5/35_N	ARHGEF5 ARHGEF35	3.76e-05	2	115	2	IPR029212
Domain	RimK	RIMKLA RIMKLB	3.76e-05	2	115	2	PF08443
Domain	RpS6_RimK/Lys_biosynth_LsyX	RIMKLA RIMKLB	3.76e-05	2	115	2	IPR004666
Domain	PRTase-like	PRPS2 PRPS1L1 PRPS1	4.80e-05	12	115	3	IPR029057
Domain	PRibTrfase_dom	PRPS2 PRPS1L1 PRPS1	4.80e-05	12	115	3	IPR000836
Domain	-	PRPS2 PRPS1L1 PRPS1	4.80e-05	12	115	3	3.40.50.2020
Domain	6-Pfructokinase_euk	PFKL PFKM	1.12e-04	3	115	2	IPR009161
Domain	PHOSPHOFRUCTOKINASE	PFKL PFKM	1.12e-04	3	115	2	PS00433
Domain	Phosphofructokinase_CS	PFKL PFKM	1.12e-04	3	115	2	IPR015912
Domain	PFK	PFKL PFKM	1.12e-04	3	115	2	PF00365
Domain	ATP_PFK	PFKL PFKM	1.12e-04	3	115	2	IPR022953
Domain	Phosphofructokinase_dom	PFKL PFKM	1.12e-04	3	115	2	IPR000023
Domain	ATPase_P-typ_cation-transptr_N	ATP13A2 ATP2C2 ATP13A3	2.05e-04	19	115	3	IPR004014
Domain	P5-ATPase	ATP13A2 ATP13A3	2.24e-04	4	115	2	PF12409
Domain	GLTP	PLEKHA8P1 PLEKHA8	2.24e-04	4	115	2	PF08718
Domain	Glycolipid_transfer_prot_dom	PLEKHA8P1 PLEKHA8	2.24e-04	4	115	2	IPR014830
Domain	P-type_TPase_V	ATP13A2 ATP13A3	3.71e-04	5	115	2	IPR006544
Domain	cEGF	GAS6 HMCN1 LTBP3	5.33e-04	26	115	3	PF12662
Domain	cEGF	GAS6 HMCN1 LTBP3	5.33e-04	26	115	3	IPR026823
Domain	PH	PLEKHG4 ARHGEF5 OBSCN MPRIP CADPS PLEKHA8 RASAL1	5.43e-04	229	115	7	PF00169
Domain	EGF	SELE GAS6 MEP1B HMCN1 TENM1 ASTN1 LTBP3	6.33e-04	235	115	7	SM00181
Domain	EGF_3	SELE GAS6 MEP1B HMCN1 TENM1 ASTN1 LTBP3	6.33e-04	235	115	7	PS50026
Domain	EGF-like_dom	SELE GAS6 MEP1B HMCN1 TENM1 ASTN1 LTBP3	8.89e-04	249	115	7	IPR000742
Domain	SPEC	SESTD1 SYNE1 SPTAN1	9.90e-04	32	115	3	SM00150
Domain	Spectrin/alpha-actinin	SESTD1 SYNE1 SPTAN1	9.90e-04	32	115	3	IPR018159
Domain	EGF_1	SELE GAS6 MEP1B HMCN1 TENM1 ASTN1 LTBP3	1.02e-03	255	115	7	PS00022
Domain	EGF-like_CS	SELE GAS6 MEP1B HMCN1 TENM1 ASTN1 LTBP3	1.17e-03	261	115	7	IPR013032
Domain	EGF_2	SELE GAS6 MEP1B HMCN1 TENM1 ASTN1 LTBP3	1.27e-03	265	115	7	PS01186
Domain	ATPase_P-typ_cyto_domN	ATP13A2 ATP2C2 ATP13A3	1.29e-03	35	115	3	IPR023299
Domain	ATPase_P-typ_P_site	ATP13A2 ATP2C2 ATP13A3	1.40e-03	36	115	3	IPR018303
Domain	P_typ_ATPase	ATP13A2 ATP2C2 ATP13A3	1.40e-03	36	115	3	IPR001757
Domain	ATPASE_E1_E2	ATP13A2 ATP2C2 ATP13A3	1.40e-03	36	115	3	PS00154
Domain	ATPase_P-typ_transduc_dom_A	ATP13A2 ATP2C2 ATP13A3	1.52e-03	37	115	3	IPR008250
Domain	E1-E2_ATPase	ATP13A2 ATP2C2 ATP13A3	1.52e-03	37	115	3	PF00122
Domain	PH	PLEKHG4 ARHGEF5 OBSCN MPRIP CADPS PLEKHA8 RASAL1	1.68e-03	278	115	7	SM00233
Domain	PH_DOMAIN	PLEKHG4 ARHGEF5 OBSCN MPRIP CADPS PLEKHA8 RASAL1	1.71e-03	279	115	7	PS50003
Domain	PH_domain	PLEKHG4 ARHGEF5 OBSCN MPRIP CADPS PLEKHA8 RASAL1	1.75e-03	280	115	7	IPR001849
Domain	GDS_CDC24_CS	PLEKHG4 ARHGEF5 OBSCN	1.77e-03	39	115	3	IPR001331
Domain	Rho_GTPase_activation_prot	TAGAP ARHGAP17 ARHGAP44 RASAL1	2.14e-03	88	115	4	IPR008936
Domain	WWE	TRIP12 TIPARP	2.38e-03	12	115	2	PF02825
Domain	WWE-dom	TRIP12 TIPARP	2.38e-03	12	115	2	IPR004170
Domain	WWE	TRIP12 TIPARP	2.38e-03	12	115	2	PS50918
Domain	-	RIMKLA RIMKLB	2.80e-03	13	115	2	3.40.50.20
Domain	Ank	ANKS4B CLIP4 EHMT1 KANK4 ANKRD36 POTEJ	2.89e-03	228	115	6	PF00023
Domain	-	PLEKHG4 ARHGEF5 OBSCN MPRIP CADPS TLN1 PLEKHA8 RASAL1	2.90e-03	391	115	8	2.30.29.30
Domain	ATP_GRASP	RIMKLA RIMKLB	3.26e-03	14	115	2	PS50975
Domain	ATP-grasp	RIMKLA RIMKLB	3.26e-03	14	115	2	IPR011761
Domain	PreATP-grasp_dom	RIMKLA RIMKLB	3.26e-03	14	115	2	IPR016185
Domain	BAR	ARHGAP17 ARHGAP44	3.74e-03	15	115	2	SM00721
Domain	BAR	ARHGAP17 ARHGAP44	3.74e-03	15	115	2	PF03114
Domain	-	RIMKLA RIMKLB	3.74e-03	15	115	2	3.30.1490.20
Domain	BAR_dom	ARHGAP17 ARHGAP44	4.26e-03	16	115	2	IPR004148
Domain	-	ANKS4B CLIP4 EHMT1 KANK4 ANKRD36 POTEJ	4.36e-03	248	115	6	1.25.40.20
Domain	ANK	ANKS4B CLIP4 EHMT1 KANK4 ANKRD36 POTEJ	4.62e-03	251	115	6	SM00248
Domain	ANK_REPEAT	ANKS4B CLIP4 EHMT1 KANK4 ANKRD36 POTEJ	4.80e-03	253	115	6	PS50088
Domain	ATPase_P-typ_cation-transptr_C	ATP2C2 ATP13A3	4.81e-03	17	115	2	IPR006068
Domain	Cation_ATPase_C	ATP2C2 ATP13A3	4.81e-03	17	115	2	PF00689
Domain	PH_dom-like	PLEKHG4 ARHGEF5 OBSCN MPRIP CADPS TLN1 PLEKHA8 RASAL1	4.86e-03	426	115	8	IPR011993
Domain	Ankyrin_rpt-contain_dom	ANKS4B CLIP4 EHMT1 KANK4 ANKRD36 POTEJ	4.89e-03	254	115	6	IPR020683
Domain	ANK_REP_REGION	ANKS4B CLIP4 EHMT1 KANK4 ANKRD36 POTEJ	4.89e-03	254	115	6	PS50297
Domain	ATP_grasp_subdomain_1	RIMKLA RIMKLB	5.39e-03	18	115	2	IPR013815
Domain	Cation_ATPase_N	ATP2C2 ATP13A3	5.39e-03	18	115	2	PF00690
Domain	-	RIMKLA RIMKLB	5.39e-03	18	115	2	3.30.470.20
Domain	Cation_ATPase_N	ATP13A2 ATP2C2	5.39e-03	18	115	2	SM00831
Domain	Ankyrin_rpt	ANKS4B CLIP4 EHMT1 KANK4 ANKRD36 POTEJ	5.67e-03	262	115	6	IPR002110
Domain	BAR	ARHGAP17 ARHGAP44	6.00e-03	19	115	2	PS51021
Domain	PRAME_family	PRAMEF7 PRAMEF8	6.00e-03	19	115	2	IPR026271
Pathway	KEGG_PENTOSE_PHOSPHATE_PATHWAY	PRPS2 PFKL PFKM PRPS1L1 PRPS1	3.80e-07	27	80	5	M1386
Pathway	REACTOME_PENTOSE_PHOSPHATE_PATHWAY	PRPS2 PRPS1L1 PRPS1	7.62e-05	15	80	3	M27682
Pathway	REACTOME_PENTOSE_PHOSPHATE_PATHWAY	PRPS2 PRPS1L1 PRPS1	7.62e-05	15	80	3	MM15404
Pubmed	Promoter regions of the human X-linked housekeeping genes PRPS1 and PRPS2 encoding phosphoribosylpyrophosphate synthetase subunit I and II isoforms.	PRPS2 PRPS1L1 PRPS1	3.81e-08	3	118	3	1314091
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	DCTN2 SPTAN1 UNC45A NCAPH SLC3A2 MPRIP KMT2C PHF3 TLN1 DIAPH3 PEAK1 ZMYM4 PCM1	5.04e-08	549	118	13	38280479
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	DCTN2 SYNE1 SPTAN1 PFKL PFKM MDH2 SLC3A2 MPRIP GDA NWD2 CADPS TLN1 ARHGAP44 HADHB PEAK1 PCM1 RASAL1 CACNA2D3 PRPS1	3.57e-07	1431	118	19	37142655
Pubmed	Clinical associations of the genetic variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves' disease.	TG FCRL3 CTLA4	3.79e-07	5	118	3	19438904
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	MON2 PRPS2 DCTN2 PSMA2 SPTAN1 PSMC4 UNC45A PFKL PFKM POLA2 NCAPH GDA PRPF4 TLN1 MAD1L1 NUP133 CNDP2 RASAL1 PRPS1	4.59e-07	1455	118	19	22863883
Pubmed	BioID Performed on Golgi Enriched Fractions Identify C10orf76 as a GBF1 Binding Protein Essential for Golgi Maintenance and Secretion.	DCTN2 UNC45A WDR11 PRPF4 TLN1 NUP133 DIAPH3 ARMH3	7.92e-07	216	118	8	31519766
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	MON2 NDOR1 OBSCN ARHGAP17 ATP13A2 MPRIP KMT2C CCDC34 TLN1 ARHGAP44 MAD1L1 EHMT1 NLRC5 LTBP3 RASAL1 GAREM1	1.08e-06	1105	118	16	35748872
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	UBR2 DCTN2 PSMA2 SPTAN1 PSMC4 UNC45A PFKL PFKM MDH2 TRIP12 MPRIP PRPF4 PHF3 TLN1 CNDP2 HADHB MAP2K2	1.10e-06	1247	118	17	27684187
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	RIMKLA ARHGEF5 SPTAN1 ARHGAP17 UNC45A TRIP12 MPRIP NEK4 PHF3 TESK2 MAD1L1 PEAK1 MAP2K2 PCM1	1.41e-06	861	118	14	36931259
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	MON2 DCTN2 PSMA2 SPTAN1 PSMC4 UNC45A PFKL PFKM MDH2 NCAPH SLC3A2 SCARB2 TLN1 NUP133 ATP13A3 HADHB PCM1 PRPS1	1.77e-06	1440	118	18	30833792
Pubmed	FAM46C and FNDC3A Are Multiple Myeloma Tumor Suppressors That Act in Concert to Impair Clearing of Protein Aggregates and Autophagy.	DCTN2 PSMA2 SPTAN1 PSMC4 PFKL MDH2 SLC3A2 HADHB	2.22e-06	248	118	8	32963011
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	DCTN2 SYNE1 SPTAN1 PSMC4 UNC45A PFKM MDH2 SLC3A2 MPRIP WDR11 TLN1 NUP133 EHMT1 CNDP2 HADHB DIAPH3 PEAK1 PCM1	2.78e-06	1487	118	18	33957083
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	UBR2 IL17REL GAS6 OBSCN E2F3 PFKL KMT2C WDR11 ARHGAP44 MAD1L1 EHMT1 CNDP2 RBM6 NLRC5 MAP2K2 SLC2A11 ZMYM4 PCM1	2.83e-06	1489	118	18	28611215
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	PLEKHG4 PSMA2 SPTAN1 TUT7 PSMC4 CASP8 UNC45A PFKL PFKM NCAPH TRIP12 SLC3A2 MPRIP WDR11 TLN1 NUP133 HADHB	3.31e-06	1353	118	17	29467282
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	SYNE1 PSMA2 SPTAN1 PSMC4 PCDHA8 MDH2 SLC3A2 TLN1 CNDP2 HADHB PEAK1 HYDIN PRPS1	3.81e-06	807	118	13	30575818
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	DCTN2 SPTAN1 PSMC4 UNC45A PFKM NCAPH TRIP12 TLN1 MAD1L1 DIAPH3 MAP2K2	4.99e-06	582	118	11	20467437
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	PRPS2 SYNE1 PSMA2 SPTAN1 PFKM MDH2 NCAPH TRIP12 SLC3A2 PRPS1L1 RFTN1 RIMKLB TENM1 HADHB DIAPH3 POTEJ PRPS1	7.66e-06	1442	118	17	35575683
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	DCTN2 SPTAN1 PSMC4 MDH2 POLA2 MPRIP PRPF4 PHF3 TLN1 POTEJ	9.32e-06	506	118	10	30890647
Pubmed	Insulin specifically regulates expression of liver and muscle phosphofructokinase isoforms.	PFKL PFKM	1.14e-05	2	118	2	29655163
Pubmed	Association of Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) and Thyroglobulin (TG) Genetic Variants with Autoimmune Hypothyroidism.	TG CTLA4	1.14e-05	2	118	2	26963610
Pubmed	Disruption of an EHMT1-associated chromatin-modification module causes intellectual disability.	KMT2C EHMT1	1.14e-05	2	118	2	22726846
Pubmed	Molecular identification of N-acetylaspartylglutamate synthase and beta-citrylglutamate synthase.	RIMKLA RIMKLB	1.14e-05	2	118	2	20657015
Pubmed	Isozyme analysis of human polymorphonuclear leukocyte phosphofructokinase from insulin resistant individuals.	PFKL PFKM	1.14e-05	2	118	2	8780720
Pubmed	The predictive value of CTLA-4 and Tg polymorphisms in the recurrence of Graves' disease after antithyroid withdrawal.	TG CTLA4	1.14e-05	2	118	2	17526951
Pubmed	The molecular mechanism of the inherited phosphofructokinase deficiency associated with hemolysis and myopathy.	PFKL PFKM	1.14e-05	2	118	2	6444532
Pubmed	[Susceptibility genes for the development of autoimmune thyroid disease].	FCRL3 CTLA4	1.14e-05	2	118	2	17154080
Pubmed	[Increased activity of PRPP synthetase].	PRPS2 PRPS1	1.14e-05	2	118	2	18409517
Pubmed	In children with autoimmune thyroiditis CTLA4 and FCRL3 genes--but not PTPN22--are overexpressed when compared to adults.	FCRL3 CTLA4	1.14e-05	2	118	2	26994388
Pubmed	PRPS1-mediated purine biosynthesis is critical for pluripotent stem cell survival and stemness.	PRPS2 PRPS1	1.14e-05	2	118	2	33493137
Pubmed	Functional convergence of histone methyltransferases EHMT1 and KMT2C involved in intellectual disability and autism spectrum disorder.	KMT2C EHMT1	1.14e-05	2	118	2	29069077
Pubmed	The glycolytic enzyme phosphofructokinase-1 assembles into filaments.	PFKL PFKM	1.14e-05	2	118	2	28646105
Pubmed	Tissue-differential expression of two distinct genes for phosphoribosyl pyrophosphate synthetase and existence of the testis-specific transcript.	PRPS2 PRPS1	1.14e-05	2	118	2	2537655
Pubmed	Periostin promotes ectopic osteogenesis of CTLA4-modified bone marrow mesenchymal stem cells.	POSTN CTLA4	1.14e-05	2	118	2	28687929
Pubmed	Large-scale analysis of the human ubiquitin-related proteome.	UBR2 DCTN2 PSMA2 PSMC4 RIMKLB PRPF4 NUP133 HADHB	1.22e-05	313	118	8	16196087
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	PLEKHG4 TAGAP ARHGEF5 PSMA2 ARHGAP17 UNC45A SLC3A2 MPRIP TLN1 ARHGAP44 RBM6 HADHB PEAK1	1.47e-05	916	118	13	32203420
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	PRPS2 SPTAN1 PSMC4 PFKL TRIP12 MPRIP PRPF4 NUP133 HADHB POTEJ PCM1	1.61e-05	660	118	11	32780723
Pubmed	Requirement for the Mitochondrial Pyruvate Carrier in Mammalian Development Revealed by a Hypomorphic Allelic Series.	PRPS2 PFKL MDH2 PRPS1L1 PRPS1	1.69e-05	93	118	5	27215380
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	PSMA2 PSMC4 PFKL PFKM SLC3A2 KMT2C PRPF4 TLN1 ZFP91 EHMT1 HADHB ZMYM4 PCM1 PRPS1	2.34e-05	1103	118	14	34189442
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	PRPS2 INTS7 SPTAN1 PSMC4 UNC45A PFKL PFKM MDH2 NCAPH SLC3A2 GDA PRPF4 TLN1 HADHB DIAPH3 PRPS1	2.42e-05	1415	118	16	28515276
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	SYNE1 SPTAN1 PSMC4 UNC45A PFKL PFKM MDH2 NCAPH SLC3A2 PRPF4 TLN1 NUP133 EHMT1 HADHB PEAK1 PRPS1	2.63e-05	1425	118	16	30948266
Pubmed	Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4.	SYNE1 NEK4 MAD1L1 LINC02694 CCS	2.64e-05	102	118	5	21926972
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	SPTAN1 UNC45A NCAPH SLC3A2 TLN1 DIAPH3 PCM1	2.84e-05	256	118	7	33397691
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	DCTN2 UNC45A TRIP12 SLC3A2 MPRIP PRPF4 PHF3 ZFP91 NUP133 EHMT1 HADHB ZMYM4	3.25e-05	847	118	12	35850772
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	MON2 PSMC4 ARHGAP17 E2F3 MPRIP RBM6 DIAPH3 POTEJ ZMYM4 PCM1	3.36e-05	588	118	10	38580884
Pubmed	N-acetylaspartylglutamate synthetase II synthesizes N-acetylaspartylglutamylglutamate.	RIMKLA RIMKLB	3.42e-05	3	118	2	21454531
Pubmed	Role of emerging vitamin K‑dependent proteins: Growth arrest‑specific protein 6, Gla‑rich protein and periostin (Review).	GAS6 POSTN	3.42e-05	3	118	2	33448308
Pubmed	Functional expression of human mutant phosphofructokinase in yeast: genetic defects in French Canadian and Swiss patients with phosphofructokinase deficiency.	PFKL PFKM	3.42e-05	3	118	2	7825568
Pubmed	Partial reconstitution of mammalian phosphoribosylpyrophosphate synthetase in Escherichia coli cells. Coexpression of catalytic subunits with the 39-kDa associated protein leads to formation of soluble multimeric complexes of various compositions.	PRPS2 PRPS1	3.42e-05	3	118	2	9366267
Pubmed	Isozymes of human phosphofructokinase: identification and subunit structural characterization of a new system.	PFKL PFKM	3.42e-05	3	118	2	6444721
Pubmed	NAAG synthetase deficiency has only low influence on pathogenesis in a Canavan disease mouse model.	RIMKLA RIMKLB	3.42e-05	3	118	2	38011891
Pubmed	Genomic organization, 5'flanking region and tissue-specific expression of mouse phosphofructokinase C gene.	PFKL PFKM	3.42e-05	3	118	2	11137296
Pubmed	The copper chaperone CCS facilitates copper binding to MEK1/2 to promote kinase activation.	MAP2K2 CCS	3.42e-05	3	118	2	34715128
Pubmed	Molecular mechanism of c-Myc and PRPS1/2 against thiopurine resistance in Burkitt's lymphoma.	PRPS2 PRPS1	3.42e-05	3	118	2	32391636
Pubmed	Alleles from chromosomes 1 and 3 of NOD mice combine to influence Sjögren's syndrome-like autoimmune exocrinopathy.	CASP8 CTLA4	3.42e-05	3	118	2	10955330
Pubmed	Cloning of cDNAs for human phosphoribosylpyrophosphate synthetases 1 and 2 and X chromosome localization of PRPS1 and PRPS2 genes.	PRPS2 PRPS1	3.42e-05	3	118	2	1962753
Pubmed	Phosphofructokinase isozyme expression during myoblast differentiation.	PFKL PFKM	3.42e-05	3	118	2	2521854
Pubmed	Biochemical and transcript level differences between the three human phosphofructokinases show optimisation of each isoform for specific metabolic niches.	PFKL PFKM	3.42e-05	3	118	2	33141153
Pubmed	Expression of phosphoribosyl pyrophosphate synthetase genes in U87 glioma cells with ERN1 knockdown: effect of hypoxia and endoplasmic reticulum stress.	PRPS2 PRPS1	3.42e-05	3	118	2	25816608
Pubmed	Phosphofructokinase (PFK) isozymes in man. I. Studies of adult human tissues.	PFKL PFKM	3.42e-05	3	118	2	156693
Pubmed	Isozymes of human phosphofructokinase in blood cells and cultured cell lines: molecular and genetic evidence for a trigenic system.	PFKL PFKM	3.42e-05	3	118	2	6451249
Pubmed	Characterization of the enzymatic defect in late-onset muscle phosphofructokinase deficiency. New subtype of glycogen storage disease type VII.	PFKL PFKM	3.42e-05	3	118	2	2960695
Pubmed	Arginylation regulates purine nucleotide biosynthesis by enhancing the activity of phosphoribosyl pyrophosphate synthase.	PRPS2 PRPS1	3.42e-05	3	118	2	26175007
Pubmed	Variation in the lymphotoxin-alpha/tumor necrosis factor locus modifies risk of erythema nodosum in sarcoidosis.	SELE CTLA4 C5	3.55e-05	19	118	3	19225544
Pubmed	Reduction of Nipbl impairs cohesin loading locally and affects transcription but not cohesion-dependent functions in a mouse model of Cornelia de Lange Syndrome.	PCDHB14 PCDH11X MAP2K2	3.55e-05	19	118	3	23920377
Pubmed	Mass spectrometric analysis of lysine ubiquitylation reveals promiscuity at site level.	UBR2 DCTN2 PSMA2 RIMKLB PRPF4 NUP133	3.61e-05	180	118	6	21139048
Pubmed	Genetics of rheumatoid arthritis contributes to biology and drug discovery.	TAGAP CASP8 FCRL3 CTLA4 C5	4.15e-05	112	118	5	24390342
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	MON2 PRPS2 RMND5B SESTD1 DCTN2 PSMA2 WRN PSMC4 MPRIP NEK4 POSTN PRPF4 TESK2 ARHGAP44 NUP133	4.23e-05	1321	118	15	27173435
Pubmed	Spatiotemporal Analysis of a Glycolytic Activity Gradient Linked to Mouse Embryo Mesoderm Development.	PRPS2 PFKL PFKM MDH2 PRPS1	4.51e-05	114	118	5	28245920
Pubmed	Progesterone induced Warburg effect in HEK293 cells is associated with post-translational modifications and proteasomal degradation of progesterone receptor membrane component 1.	PFKL PFKM MPRIP MAP2K2	4.64e-05	58	118	4	31067491
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	INTS7 SYNE1 WRN UNC45A PFKL SLC3A2 MPRIP KMT2C RFTN1 WDR11 PHF3 TLN1 ZFP91 EHMT1 RBM6 ZMYM4	4.75e-05	1497	118	16	31527615
Pubmed	CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.	UBR2 SPTAN1 PSMC4 PFKL PFKM MDH2 TLN1 NUP133 RBM6	4.98e-05	494	118	9	26831064
Pubmed	Network organization of the huntingtin proteomic interactome in mammalian brain.	SPTAN1 PSMC4 GRIK5 PFKL PFKM MDH2 SLC3A2 GDA HADHB RASAL1	5.31e-05	621	118	10	22794259
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	INTS7 SYNE1 SPTAN1 UNC45A MDH2 NCAPH EHMT1 RBM6 ASTN1 HADHB ZMYM4	5.41e-05	754	118	11	35906200
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	POLA2 NCAPH TRIP12 PHF3 MAD1L1 NUP133 RBM6 MAP2K2 PCM1	5.72e-05	503	118	9	16964243
Pubmed	The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1.	SYNE1 PSMA2 SPTAN1 PFKL PRPS1L1 TLN1	5.96e-05	197	118	6	20811636
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	SPTAN1 TUT7 WRN PSMC4 UNC45A MDH2 TRIP12 MPRIP PHF3 TLN1 ZFP91 C5 HADHB POTEJ PCM1	6.43e-05	1371	118	15	36244648
Pubmed	Analysis of Hemicentin-1, hOgg1, and E-selectin single nucleotide polymorphisms in age-related macular degeneration.	SELE HMCN1	6.82e-05	4	118	2	17057786
Pubmed	Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity.	NDOR1 CTLA4	6.82e-05	4	118	2	26371185
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	WRN MAGEC3 NCAPH TRIP12 SLC3A2 WDR11 EHMT1 PEAK1 PLEKHA8 PCM1 PRPS1	7.07e-05	777	118	11	35844135
Pubmed	TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions.	DCTN2 SPTAN1 PSMC4 E2F3 NCAPH MPRIP PRPS1L1 RIMKLB CCDC34 EHMT1 HADHB PRPS1	7.31e-05	922	118	12	27609421
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	PSMC4 PFKM MPRIP KMT2C PHF3 TLN1	8.04e-05	208	118	6	33230847
Pubmed	Loss of connectin novex-3 leads to heart dysfunction associated with impaired cardiomyocyte proliferation and abnormal nuclear mechanics.	SYNE1 OBSCN PCM1	8.29e-05	25	118	3	38877142
Pubmed	Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation.	INTS7 DCTN2 PSMC4 UNC45A PFKM SLC3A2 NUP133 DIAPH3 MAP2K2	9.02e-05	534	118	9	35032548
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	PRPS2 SPTAN1 TUT7 UNC45A PFKL NCAPH TRIP12 SLC3A2 MPRIP WDR11 PRPF4 PHF3 NUP133 HADHB	9.52e-05	1257	118	14	36526897
Pubmed	Direct interaction between the PRDM3 and PRDM16 tumor suppressors and the NuRD chromatin remodeling complex.	PSMC4 PFKL NCAPH SLC3A2 WDR11 NUP133	9.64e-05	215	118	6	30462309
Pubmed	Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics.	PRPS2 PFKM MDH2 SLC3A2 SCARB2 TLN1 HADHB PRPS1	1.01e-04	422	118	8	27342126
Pubmed	IDD3 and IDD5 alleles from nod mice mediate Sjögren's syndrome-like autoimmunity.	CASP8 CTLA4	1.13e-04	5	118	2	12614028
Pubmed	Linkage of phosphoribosylpyrophosphate synthetases 1 and 2, Prps1 and Prps2, on the mouse X chromosome.	PRPS2 PRPS1	1.13e-04	5	118	2	7849396
Pubmed	Mitogen-inducible SIPA1 is mapped to the conserved syntenic groups of chromosome 19 in mouse and chromosome 11q13.3 centromeric to BCL1 in human.	SLC3A2 LTBP3	1.13e-04	5	118	2	9027487
Pubmed	PRP4 is a spindle assembly checkpoint protein required for MPS1, MAD1, and MAD2 localization to the kinetochores.	PRPF4 MAD1L1	1.13e-04	5	118	2	17998396
Pubmed	CTLA-4-/- mice display T cell-apoptosis resistance resembling that ascribed to autoimmune-prone non-obese diabetic (NOD) mice.	CASP8 CTLA4	1.13e-04	5	118	2	11247636
Pubmed	Characterization of the P5 subfamily of P-type transport ATPases in mice.	ATP13A2 ATP13A3	1.13e-04	5	118	2	15381061
Pubmed	Convallatoxin inhibits IL-1β production by suppressing zinc finger protein 91 (ZFP91)-mediated pro-IL-1β ubiquitination and caspase-8 inflammasome activity.	CASP8 ZFP91	1.13e-04	5	118	2	34825365
Pubmed	ZFP91 promotes cell proliferation and inhibits cell apoptosis in AML via inhibiting the proteasome-dependent degradation of RIP1.	CASP8 ZFP91	1.13e-04	5	118	2	35165513
Pubmed	Parkinson disease related ATP13A2 evolved early in animal evolution.	ATP13A2 ATP13A3	1.13e-04	5	118	2	29505581
Pubmed	Zinc finger protein 91 positively regulates the production of IL-1β in macrophages by activation of MAPKs and non-canonical caspase-8 inflammasome.	CASP8 ZFP91	1.13e-04	5	118	2	30182366
Pubmed	The coinhibitory receptor CTLA-4 controls B cell responses by modulating T follicular helper, T follicular regulatory, and T regulatory cells.	NDOR1 CTLA4	1.13e-04	5	118	2	25526313
Pubmed	Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally.	CASP8 CTLA4	1.13e-04	5	118	2	9729047
Pubmed	The E3 ubiquitin ligase and RNA-binding protein ZNF598 orchestrates ribosome quality control of premature polyadenylated mRNAs.	DCTN2 SPTAN1 PSMC4 NCAPH SLC3A2 SCARB2 NUP133	1.15e-04	320	118	7	28685749
Pubmed	Differences in gene expression between mouse and human for dynamically regulated genes in early embryo.	PRAMEF7 PRAMEF8 NLRP9	1.17e-04	28	118	3	25089626
GeneFamily	Parkinson disease associated genes\|ATPase orphan transporters	ATP13A2 ATP13A3	1.87e-04	5	79	2	1213
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	PLEKHG4 ARHGEF5 OBSCN ARHGEF35	1.98e-04	66	79	4	722
GeneFamily	Ankyrin repeat domain containing	ANKS4B CLIP4 EHMT1 KANK4 ANKRD36 POTEJ	6.65e-04	242	79	6	403
GeneFamily	N-BAR domain containing	ARHGAP17 ARHGAP44	1.21e-03	12	79	2	1289
GeneFamily	Rho GTPase activating proteins\|BCH domain containing	TAGAP ARHGAP17 ARHGAP44	1.36e-03	50	79	3	721
GeneFamily	Gla domain containing	GAS6 POSTN	1.43e-03	13	79	2	1250
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	PLEKHG4 MPRIP CADPS PLEKHA8 RASAL1	2.08e-03	206	79	5	682
GeneFamily	PRAME family	PRAMEF7 PRAMEF8	4.89e-03	24	79	2	686
GeneFamily	NLR family	NLRP9 NLRC5	5.30e-03	25	79	2	666
GeneFamily	C2-set domain containing\|Immunoglobulin like domain containing\|Scavenger receptors	CD163L1 SCARB2	6.16e-03	27	79	2	1253
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	UBR2 WRN CASP8 E2F3 TRIP12 TIPARP RFTN1 PHF3 RBM6 ATP13A3 ZMYM4	8.65e-06	466	118	11	M13522
Coexpression	CAFFAREL_RESPONSE_TO_THC_8HR_3_DN	PCDHB14 POLA2 PRPS1	1.04e-05	10	118	3	M14648
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	UBR2 WRN CASP8 E2F3 TRIP12 TIPARP NEK4 RFTN1 PHF3 MAD1L1 NUP133 RBM6 ATP13A3 ZMYM4	3.17e-05	856	118	14	M4500
Coexpression	GSE25087_FETAL_VS_ADULT_TCONV_UP	INTS7 PSMA2 PSMC4 TRIP12 TIPARP PRPF4 ZMYM4	3.39e-05	199	118	7	M4645
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MON2 UBR2 SYNE1 CASP8 PHF3 TENM1 NLRC5 ANKRD36 PCM1	3.19e-09	199	118	9	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MXRA5 GRIK5 ARHGAP44 PCDH11X KANK4 CACNA2D3	1.00e-05	185	118	6	7dcdc009c5681ee05dd18968f7e85c3403fe34af
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1\|Adult / Lineage, Cell type, age group and donor	RIMKLA GAS6 ARHGAP44 DIAPH3 PEAK1 CACNA2D3	1.07e-05	187	118	6	77f78aec946bc6bd85c29aee9ca978ce49f853a3
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TAGAP SYNE1 CASP8 RFTN1 FCRL3 ANKRD36	1.17e-05	190	118	6	d153a0bdedcd6865e6ee19575234a78b5d859ff1
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SYNE1 CASP8 KMT2C TENM1 ANKRD36 PCM1	1.43e-05	197	118	6	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SYNE1 SPTAN1 CADPS ARHGAP44 PCDH11X CACNA2D3	1.47e-05	198	118	6	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TAGAP JAML RFTN1 NLRC5 CTLA4 LINC02694	1.56e-05	200	118	6	d8459e45a8396a9ee063666a1928c649162c5727
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-T_reg\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TG RFTN1 FCRL3 NLRC5 CTLA4 LINC02694	1.56e-05	200	118	6	68589705dbc84482b6c0a1a27dd552492c4e8c3d
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	UBR2 CASP8 TRIP12 KMT2C PHF3 PCM1	1.56e-05	200	118	6	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse\|TCGA-Stomach / Sample_Type by Project: Shred V9	SYNE1 ITGAD RFTN1 FCRL3 POTEJ	2.42e-05	129	118	5	7d537680b0dfb764f7914d0475c66b678b5cb8d2
ToppCell	Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Resp18_(Bed_nucleus_of_the_stria_terminalis_(BNST))-\|Striatum / BrainAtlas - Mouse McCarroll V32	PCDHA8 ANKS4B BNC1 ATP2C2	3.22e-05	68	118	4	ea33633d93a3a7f82c9abf11472fcfb55b0c4878
ToppCell	Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Resp18_(Bed_nucleus_of_the_stria_terminalis_(BNST))--\|Striatum / BrainAtlas - Mouse McCarroll V32	PCDHA8 ANKS4B BNC1 ATP2C2	3.22e-05	68	118	4	5058dcaf02cc893cfd16032e0034dd9fa097c0b8
ToppCell	Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Resp18_(Bed_nucleus_of_the_stria_terminalis_(BNST))\|Striatum / BrainAtlas - Mouse McCarroll V32	PCDHA8 ANKS4B BNC1 ATP2C2	3.22e-05	68	118	4	41a697c4628acc8a0f5df2f463c1fdc6ee9b7942
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	NDOR1 JAML TENM1 CTLA4 RASAL1	3.58e-05	140	118	5	7b359bfbd404ab06d799048252f4985d85852048
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HMCN1 ASTN1 KLF18 HYDIN CACNA2D3	6.76e-05	160	118	5	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HMCN1 ASTN1 KLF18 HYDIN CACNA2D3	6.76e-05	160	118	5	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDHA8 PFKM ASTN1 TBC1D21 ZMYM4	7.38e-05	163	118	5	953a7db7e90a913e81002d2141fbbd5f1fdf2197
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GDA RIMKLB TENM1 DIAPH3 HYDIN	7.60e-05	164	118	5	1cb5fbd7050650047ad6f2ca792118e98d58d22b
ToppCell	368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	RIMKLA PCDHB14 GRIK5 BNC1 DIAPH3	8.05e-05	166	118	5	4d63c758d46e73311b864148c646bf081498dee7
ToppCell	368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)\|368C / Donor, Lineage, Cell class and subclass (all cells)	RIMKLA PCDHB14 GRIK5 BNC1 DIAPH3	8.05e-05	166	118	5	4160ccf9291072a6e2782f9ad141bc9a9747f3ad
ToppCell	343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell\|343B / Donor, Lineage, Cell class and subclass (all cells)	NCAPH TG CCDC34 CTLA4 LINC02694	8.28e-05	167	118	5	315cde87eed2b42a1b9b068fae94caa10ec64c70
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse-3\|TCGA-Stomach / Sample_Type by Project: Shred V9	ITGAD JAML RFTN1 FCRL3 HMCN1	8.28e-05	167	118	5	d2230c894ccf9dbba9196e079ae81f384d43da63
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_5\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	PLEKHG4 PDLIM4 POSTN HMCN1 CADPS	8.75e-05	169	118	5	d2def7229fe9d6b0c70cfed349ede491c8c137a0
ToppCell	Basal_cells-SSc-ILD_02\|World / lung cells shred on cell class, cell subclass, sample id	MXRA5 PCDHB14 PDLIM4 TG RIMKLB	9.00e-05	170	118	5	776d4224a682b6c648041827efd69794f88906f0
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAGEC3 ANKS4B JAML RFTN1 CTLA4	9.51e-05	172	118	5	72fbfa890995e47048b47199c170cc7dcd7661f8
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAGEC3 ANKS4B JAML RFTN1 CTLA4	9.51e-05	172	118	5	2ca6f0d1181aabe0d0e3e8f2e193f08dbda42dea
ToppCell	PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PRPS1L1 GDA CCDC34 NUP133 DIAPH3	1.00e-04	174	118	5	65147b0f8c2ccadd5685430d31081520c157536a
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Enterocyte\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGEF5 ANKS4B MEP1B GDA PLEKHA8	1.00e-04	174	118	5	2fbdb62e269acf4447b171700a615e878dde7f9f
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-enterocyte_of_epithelium_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGEF5 ANKS4B MEP1B GDA PLEKHA8	1.00e-04	174	118	5	7c52b5d8f1e65e5208c952be341fa155ed0e6e76
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1-Excitatory_Neuron.Sc17a7.Calb1-Lpl_(Layer_2/3)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	HJV PLEKHG4 BNC1 ATP2C2	1.05e-04	92	118	4	dfe63bb979f0382163955b32909ffab1de37685a
ToppCell	cellseq2-Mesenchymal-Myocytic-Myocytic_1-Pericyte\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	GAS6 RFTN1 CD163L1 DIAPH3 SLC2A11	1.09e-04	177	118	5	68263456a3c93cd195b321b309ff59e156d732fe
ToppCell	cellseq2-Mesenchymal-Myocytic-Myocytic_1\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	GAS6 RFTN1 CD163L1 DIAPH3 SLC2A11	1.09e-04	177	118	5	e415e448c37adc102d766235e9953dec32c021f1
ToppCell	368C-Myeloid-Macrophage-SPP1+_Macrophage_3\|368C / Donor, Lineage, Cell class and subclass (all cells)	TUT7 WRN KMT2C WDR11 GAREM1	1.12e-04	178	118	5	536a601abcc60867949ea06e9aafb6c7b799b56b
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RIMKLA GAS6 ARHGAP44 DIAPH3 CACNA2D3	1.15e-04	179	118	5	4f6ca313b78aa93557937a046c44dcf8bcc9963c
ToppCell	droplet-Tongue-nan-24m-Myeloid-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TAGAP JAML RFTN1 CD163L1 CTLA4	1.15e-04	179	118	5	1b079d80f789473701c781f3431ad306e9766797
ToppCell	droplet-Heart-4Chambers-18m-Mesenchymal-cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HJV OBSCN PFKM TG CACNA2D3	1.21e-04	181	118	5	09a574a3257e25c8b05a2ab20623a6b07331411a
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	WRN RFTN1 TENM1 CTLA4 PRPS1	1.21e-04	181	118	5	986c036e656f24fe374807e2711cec9e3c83c892
ToppCell	droplet-Heart-4Chambers-18m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HJV OBSCN PFKM TG CACNA2D3	1.21e-04	181	118	5	ac4142aa93706b7067f63d2d38e2456859e60768
ToppCell	ASK454-Epithelial\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	SPTAN1 GAS6 LTBP3 DIAPH3 HYDIN	1.24e-04	182	118	5	ab15316cff989b61ff397a866d7ca8b49c13e981
ToppCell	CTRL-Myeloid-cDC\|Myeloid / Disease state, Lineage and Cell class	GAS6 RFTN1 CTLA4 RASAL1 CACNA2D3	1.24e-04	182	118	5	ee137574b8f0e684a4a7cb26226877c471cae433
ToppCell	356C-Lymphocytic-CD4_T-cell-Treg_cell_2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	SESTD1 NCAPH CTLA4 HADHB LINC02694	1.27e-04	183	118	5	f142b320023eef00b48d4820c46214c9794d37e7
ToppCell	10x5'v1-week_17-19-Lymphocytic_T-T_NK-Treg\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	CLIP4 ARHGEF35 FCRL3 TENM1 CTLA4	1.27e-04	183	118	5	5fb933acfe6bc555c90dba71e75d4be658763945
ToppCell	343B-Lymphocytic-CD4_T-cell-Treg_cell_4\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	E2F3 NUP133 CNDP2 CTLA4 LINC02694	1.27e-04	183	118	5	3cbe0175d05fd39bc430de1ef471ff2c5b56460e
ToppCell	LPS_only-Epithelial_alveolar-AT_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGAP44 KANK4 C5 CACNA2D3 GAREM1	1.27e-04	183	118	5	e972432dd4d1bd31bb0982f4df3061e5e152658f
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN HMCN1 PCDH11X TENM1 HYDIN	1.30e-04	184	118	5	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN HMCN1 PCDH11X TENM1 HYDIN	1.30e-04	184	118	5	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SPTAN1 ARHGEF35 FCRL3 CTLA4 LINC02694	1.30e-04	184	118	5	08bff25390e3484b75c860738396a405141b69fd
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN HMCN1 PCDH11X TENM1 HYDIN	1.30e-04	184	118	5	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGAP44 KANK4 C5 CACNA2D3 GAREM1	1.30e-04	184	118	5	ab2f06906fc7a9931dfa0864ef506832b07fb93e
ToppCell	356C-Lymphocytic-CD4_T-cell-Treg_cell_2\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	SESTD1 NCAPH CTLA4 HADHB LINC02694	1.34e-04	185	118	5	e06a784a297f357f3f8e761c24fa70722048ab42
ToppCell	LPS_only-Epithelial_alveolar-AT_1-AT1-AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGAP44 KANK4 C5 CACNA2D3 GAREM1	1.34e-04	185	118	5	68f428e169cfb77de970bdfdeea9b9f16f68d2ba
ToppCell	LPS_only-Epithelial_alveolar\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGAP44 KANK4 C5 CACNA2D3 GAREM1	1.37e-04	186	118	5	e0a2ea4b46af742bc7c9b2072bb85e27d5c92712
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SYNE1 TENM1 DIAPH3 HYDIN CACNA2D3	1.37e-04	186	118	5	f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	MXRA5 GRIK5 PCDH11X KANK4 CACNA2D3	1.41e-04	187	118	5	5258674d0346e5c51a4b965efcdc1790c970845d
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RIMKLB TENM1 DIAPH3 HYDIN CACNA2D3	1.41e-04	187	118	5	c31130fc2f9f882944b2ba366a034a03f051c4b9
ToppCell	PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_migrating_dendritic_(5)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	TAGAP ITGAD JAML CD163L1 CTLA4	1.44e-04	188	118	5	8fc15c8b78fdd1a578e34325011bc5a87a8aab31
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGAP44 KANK4 C5 CACNA2D3 GAREM1	1.44e-04	188	118	5	4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCell	3'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TAGAP FCRL3 MAD1L1 NLRC5 RASAL1	1.44e-04	188	118	5	7447051dcdb949adc6af5814188674a489adf71f
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SESTD1 PDLIM4 RIMKLB DIAPH3 CACNA2D3	1.48e-04	189	118	5	8c8ca3b30d9be6c854615459a7bfba82b427c8bc
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SESTD1 PDLIM4 RIMKLB DIAPH3 CACNA2D3	1.48e-04	189	118	5	5d902a4660a27548764bf04c6de152b565da835c
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPTAN1 GAS6 MPRIP HMCN1 TLN1	1.52e-04	190	118	5	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SESTD1 DIAPH3 RASAL1 CACNA2D3 GAREM1	1.55e-04	191	118	5	9032aa974aa1b7b1095b8d1b58dcb087358a5001
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SESTD1 DIAPH3 RASAL1 CACNA2D3 GAREM1	1.55e-04	191	118	5	5717809a1476c20f65bce722c5a57cff92ee0d7a
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SYNE1 SPTAN1 CASP8 TENM1 CTLA4	1.55e-04	191	118	5	4a29b7d5cd10e9077699d3aa76e3db6c4d5a0cf6
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SPTAN1 CASP8 MAD1L1 CTLA4 LINC02694	1.59e-04	192	118	5	7a90ec9fc8f29216c4828e0cf5d040906456e53b
ToppCell	COVID-19_Severe-Lymphoid_T/NK-Treg\|COVID-19_Severe / Disease group, lineage and cell class	SPTAN1 CASP8 MAD1L1 CTLA4 LINC02694	1.59e-04	192	118	5	3fb4c148dadcf5e79094e55c6bb53ec7bf9d44c8
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	SPTAN1 CASP8 MAD1L1 CTLA4 LINC02694	1.59e-04	192	118	5	d883b91bbab71673de4858346d3ab33e5fbbf842
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SESTD1 SYNE1 DIAPH3 CACNA2D3 GAREM1	1.63e-04	193	118	5	f42a0f02ed00fe1bb833ff0a0640d9131bca89bd
ToppCell	5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRPS2 IL17REL GAS6 PCDH11X ASTN1	1.63e-04	193	118	5	c5bd0ed6f57459e54d2463318e8d9b1879718e63
ToppCell	Control-Myeloid-cDC2\|Myeloid / Disease state, Lineage and Cell class	GAS6 JAML RFTN1 CTLA4 RASAL1	1.63e-04	193	118	5	4cb938c346cc32ec122d11e6b9f25db20e0f7ff6
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SYNE1 E2F3 FCRL3 TENM1 NLRC5	1.63e-04	193	118	5	523e2541f9f8d22b3c5263839a57cc1ab23d4963
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SESTD1 SYNE1 DIAPH3 CACNA2D3 GAREM1	1.63e-04	193	118	5	42df7ed37d11fb542b4d1d714b6f87ae8e1396a6
ToppCell	moderate-Epithelial-FOXN4+\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	PRPS2 CCDC34 ATP2C2 ANKRD36 PCM1	1.67e-04	194	118	5	5dffa578149104dda33774361e9e77b227b5f1ce
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SYNE1 DIAPH3 HYDIN CACNA2D3 GAREM1	1.67e-04	194	118	5	e577d9e88390b36b5a09b97fe1026089892275a3
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)\|390C / Donor, Lineage, Cell class and subclass (all cells)	UBR2 ARHGEF5 GAS6 ATP2C2 RBM6	1.67e-04	194	118	5	88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d
ToppCell	Tracheal-10x3prime_v2-Epithelial-Epi_submucosal-gland\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	RIMKLA KANK4 ELF5 DIAPH3 RASAL1	1.67e-04	194	118	5	e90f6717e3421f8978d1fc1b2f30dcf69f6fcce7
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	UBR2 ARHGEF5 GAS6 ATP2C2 RBM6	1.67e-04	194	118	5	a71728202493d4858342ea2756ea281cd0d99a3a
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SESTD1 TENM1 DIAPH3 CACNA2D3 GAREM1	1.71e-04	195	118	5	938b31dbf1674ee6fd0123bc88391ddcaf151217
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SYNE1 CASP8 FCRL3 TENM1 NLRC5	1.71e-04	195	118	5	42382653e977714bff453bece26a6cd66ea2cc1f
ToppCell	COVID_non-vent-Lymphocytic-T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	SPTAN1 OBSCN MPRIP ANKRD36 CTLA4	1.71e-04	195	118	5	4bdedd924564a260841a9153604026b57487c83d
ToppCell	BLOOD--(1)_Activated_T_cells\| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	NCAPH MPRIP CTLA4 DIAPH3 LINC02694	1.71e-04	195	118	5	45515d5da8a8c8242eb70a1bea24fe44eca5407b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SESTD1 TENM1 DIAPH3 CACNA2D3 GAREM1	1.71e-04	195	118	5	d39e9e6544f49e677ebe528c6fe60b99a3630e30
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SESTD1 RIMKLA GAS6 ARHGAP44 DIAPH3	1.75e-04	196	118	5	eb68f7954e7c2f86d05e740e95b6e74805a6053f
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SYNE1 E2F3 FCRL3 TLN1 TENM1	1.75e-04	196	118	5	17f17edadafdad9f24e88d708d7e1c765503131c
ToppCell	COVID_non-vent-Lymphocytic\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	SYNE1 SPTAN1 MPRIP FCRL3 ANKRD36	1.79e-04	197	118	5	c672915f8c8c1e948d251f6eaf9f84a5600c1193
ToppCell	mild-low-quality_cells\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SYNE1 CASP8 TENM1 NLRC5 ANKRD36	1.79e-04	197	118	5	e4331969bd911d1ebb5453f40a7057297b5389b4
ToppCell	mild-Treg\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SPTAN1 CASP8 FCRL3 MAD1L1 CTLA4	1.79e-04	197	118	5	39800e6e83f2d333b753d121c7aeb2912b91faa2
ToppCell	5'-GW_trimst-2-LymphNode-Mesenchymal\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRPS2 IL17REL GAS6 PCDH11X ASTN1	1.79e-04	197	118	5	5fbbc570a4e77c703f569a4f85ce2d8af67d6297
ToppCell	URO-Myeloid-cDC2\|URO / Disease, Lineage and Cell Type	PSMA2 GAS6 PSMC4 JAML CACNA2D3	1.79e-04	197	118	5	7fee14356d7fba68a0515c8b9284568d14124b0a
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD4\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	TAGAP CASP8 JAML CTLA4 LINC02694	1.84e-04	198	118	5	f486747f2c96b403bdeee0dfe0cc2679ffeefa33
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NCAPH POSTN NLRP9 CCDC34 DIAPH3	1.84e-04	198	118	5	1fa213e79d828bff6465bde116536dd1b80d94e0
ToppCell	systemic_lupus_erythematosus-flare\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SYNE1 PSMA2 PHF3 ANKRD36 PCM1	1.84e-04	198	118	5	4c93ee921d56132d80832d8e94563f32ccf13bbc
ToppCell	343B-Myeloid-Dendritic-cDC_proliferating_1\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	POLA2 NCAPH CCDC34 DIAPH3 CACNA2D3	1.84e-04	198	118	5	281fc2536cdc4c717b30de156e563c0e4baba99d
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-T_reg\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CASP8 FCRL3 NLRC5 CTLA4 LINC02694	1.84e-04	198	118	5	7608f67959e1cda7b10e57fd3af2f96216ebe7e9
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TAGAP JAML NLRC5 CTLA4 LINC02694	1.88e-04	199	118	5	bc93e5c36ab60b66fb633c954b05d4dc09a7f152
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_GZMK+\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TAGAP JAML RFTN1 FCRL3 NLRC5	1.88e-04	199	118	5	09e0b45529fa9d5fc86da1747b3fb3a238a09aa6
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD4-CD4_TRM/EMRA\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	TAGAP CASP8 JAML NUTM1 LINC02694	1.88e-04	199	118	5	5a29db2610ba06a2248325a16cad755d20debf2c
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TAGAP JAML RFTN1 NLRC5 CTLA4	1.88e-04	199	118	5	6150b272313d3fbf5ddcb3a8d51862d368220fe2
ToppCell	healthy_donor-Lymphocytic\|healthy_donor / Disease condition, Lineage, Cell class and subclass	SYNE1 SPTAN1 FCRL3 NLRC5 ANKRD36	1.88e-04	199	118	5	2841e16d54acd344ba454f024e285c28abc37319
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SYNE1 ATP2C2 ASTN1 ANKRD36 HYDIN	1.88e-04	199	118	5	19a97e27a4758e794ce7246d295e112b47931a48
Drug	AC1L1AO2	PRPS2 PFKL PFKM PRPS1L1 PRPS1	2.67e-08	18	117	5	CID000001073
Drug	Laevuflex	PRPS2 PFKL PFKM MDH2 PRPS1L1 GDA SCARB2 EHMT1 HADHB SLC2A11 PRPS1	1.64e-07	272	117	11	CID000003426
Drug	2,5-anhydro-D-mannitol	PRPS2 PFKL PFKM PRPS1L1 PRPS1	5.02e-07	31	117	5	CID000001494
Drug	HPMPApp	PRPS2 POLA2 PRPS1L1 PRPS1	6.37e-07	14	117	4	CID000506018
Drug	MgCl2	PRPS2 PLEKHG4 PSMA2 SPTAN1 PSMC4 PFKM MDH2 POLA2 PRPS1L1 ATP2C2 PRPS1	2.19e-06	354	117	11	CID000024584
Drug	PMEApp	PRPS2 POLA2 PRPS1L1 PRPS1	2.42e-06	19	117	4	CID000447863
Drug	methyl iodoacetate	PRPS2 PRPS1L1 PRPS1	2.62e-06	6	117	3	CID006429536
Drug	APP-MP	PRPS2 PRPS1L1 PRPS1	2.62e-06	6	117	3	CID003081102
Drug	pyrimidine-5-nucleotide	PRPS2 PRPS1L1 PRPS1	2.62e-06	6	117	3	CID000440040
Drug	Compound 1-4	PRPS2 SYNE1 TIPARP PRPS1L1 PRPS1	3.04e-06	44	117	5	CID005311149
Drug	5-o-phosphonopentose	PRPS2 PSMC4 PFKM MDH2 PRPS1L1 PRPS1	3.07e-06	78	117	6	CID000000230
Drug	2,3-DPG	PRPS2 PLEKHG4 SPTAN1 PFKL PFKM PRPS1L1 PRPS1	7.00e-06	137	117	7	CID000000061
Drug	fructose-1,6-diphosphate sodium salt	PRPS2 PSMC4 PFKL PFKM MDH2 PRPS1L1 PRPS1	1.32e-05	151	117	7	CID000000718
Drug	allulose 6-phosphate	PRPS2 PSMC4 PFKL PFKM MDH2 PRPS1L1 PRPS1	2.09e-05	162	117	7	CID000000603
Drug	polyribosylribitol phosphate	PRPS2 PSMC4 PFKL PFKM PRPS1L1 PRPS1	2.49e-05	112	117	6	CID000002219
Drug	2,3,5-tri-O-benzyl-D-arabinofuranose	PFKL PFKM	2.62e-05	2	117	2	CID000255457
Drug	Dhga	PRPS2 PRPS1L1 PRPS1	2.81e-05	12	117	3	CID000467478
Drug	S)-HPMPA	PRPS2 POLA2 PRPS1L1 PRPS1	3.44e-05	36	117	4	CID000072253
Drug	2,6,6-tetramethylpiperidine	PRPS2 PRPS1L1 PRPS1	3.64e-05	13	117	3	CID000013035
Drug	2,6-diaminonebularine	PRPS2 PRPS1L1 PRPS1	3.64e-05	13	117	3	CID000072200
Drug	AC1Q6RZ4	PRPS2 PSMC4 PFKL PFKM PRPS1L1 PRPS1	4.22e-05	123	117	6	CID000000719
Drug	6-o-phosphonohexose	PRPS2 PSMC4 PFKL PFKM MDH2 PRPS1L1 PRPS1	4.88e-05	185	117	7	CID000099058
Drug	AC1L9I7L	PRPS2 PFKM PRPS1L1 SCARB2 PRPS1	5.47e-05	79	117	5	CID000445564
Drug	monomethyl succinate	PFKM MDH2 EHMT1	5.75e-05	15	117	3	CID000077487
Drug	AC1L2I23	PRPS2 PRPS1L1 PRPS1	7.05e-05	16	117	3	CID000047419
Drug	AC1L977H	PFKL PFKM	7.83e-05	3	117	2	CID000439366
Disease	amyotrophic lateral sclerosis (implicated_via_orthology)	PSMC4 ATP13A2 ATP13A3 CCS	5.17e-06	30	113	4	DOID:332 (implicated_via_orthology)
Disease	Hashimoto Disease	TG CTLA4	4.35e-05	3	113	2	C0677607
Disease	Headache, HbA1c measurement	CASP8 PFKM MAD1L1	6.92e-05	21	113	3	EFO_0004541, HP_0002315
Disease	Colorectal Carcinoma	SYNE1 PSMA2 WRN OBSCN CASP8 POSTN KMT2C PCDH11X TENM1 ZMYM4 PRPS1	8.26e-05	702	113	11	C0009402
Disease	Autoimmune thyroiditis	TG FCRL3	8.68e-05	4	113	2	C0920350
Disease	Kufor-Rakeb syndrome (implicated_via_orthology)	ATP13A2 ATP13A3	8.68e-05	4	113	2	DOID:0060556 (implicated_via_orthology)
Disease	glycogen storage disease (implicated_via_orthology)	PFKL PFKM	8.68e-05	4	113	2	DOID:2747 (implicated_via_orthology)
Disease	level of meprin A subunit beta in blood serum	MEP1B GAREM1	8.68e-05	4	113	2	OBA_2044983
Disease	juvenile-onset Parkinson's disease (implicated_via_orthology)	ATP13A2 ATP13A3	8.68e-05	4	113	2	DOID:0060893 (implicated_via_orthology)
Disease	Malignant neoplasm of breast	SYNE1 SPTAN1 OBSCN CASP8 NLRP9 FCRL3 NUP133 TENM1 EHMT1 NLRC5 HADHB PLEKHA8 PRPS1	2.43e-04	1074	113	13	C0006142
Disease	Graves Disease	FCRL3 CTLA4	5.14e-04	9	113	2	C0018213
Disease	economic and social preference	GRIK5 CADPS ARHGAP44 PCM1	5.37e-04	97	113	4	EFO_0004827
Disease	corpus callosum volume measurement	ATP13A2 TG TLN1 RBM6	6.03e-04	100	113	4	EFO_0010299
Disease	hereditary spastic paraplegia (implicated_via_orthology)	PSMC4 ATP13A2 ATP13A3	6.04e-04	43	113	3	DOID:2476 (implicated_via_orthology)
Disease	endometrial neoplasm	ZMYM4 CACNA2D3	7.82e-04	11	113	2	EFO_0004230
Disease	autoimmune thyroiditis (is_implicated_in)	TG CTLA4	9.36e-04	12	113	2	DOID:7188 (is_implicated_in)
Disease	triacylglycerol 58:12 measurement	E2F3 TRIP12	9.36e-04	12	113	2	EFO_0010439
Disease	Substance abuse problem	SYNE1 WDR11 PRPF4 ASTN1	1.05e-03	116	113	4	C0740858
Disease	corpus callosum posterior volume measurement	ATP13A2 RBM6 GAREM1	1.05e-03	52	113	3	EFO_0010298
Disease	neuronal ceroid lipofuscinosis (implicated_via_orthology)	ATP13A2 ATP13A3	1.28e-03	14	113	2	DOID:14503 (implicated_via_orthology)
Disease	Osteoporosis, Age-Related	PSMA2 PDLIM4 TLN1	1.67e-03	61	113	3	C0001787
Disease	Post-Traumatic Osteoporosis	PSMA2 PDLIM4 TLN1	1.67e-03	61	113	3	C0751406
Disease	Osteoporosis, Senile	PSMA2 PDLIM4 TLN1	1.67e-03	61	113	3	C0029459
Disease	severe acute respiratory syndrome, COVID-19	MXRA5 WRN TG CADPS PCDH11X LTBP3 CACNA2D3	1.70e-03	447	113	7	EFO_0000694, MONDO_0100096
Disease	Osteoporosis	PSMA2 PDLIM4 TLN1	1.84e-03	63	113	3	C0029456
Disease	squamous cell carcinoma (is_implicated_in)	KMT2C CTLA4	2.14e-03	18	113	2	DOID:1749 (is_implicated_in)
Disease	bipolar I disorder	SYNE1 MAD1L1 LINC02694 TBC1D21	2.15e-03	141	113	4	EFO_0009963
Disease	event free survival time, urinary bladder cancer	ARHGAP17 MAD1L1	2.38e-03	19	113	2	EFO_0000482, MONDO_0001187
Disease	Bipolar Disorder	SYNE1 CASP8 GRIK5 PFKL NEK4 CTLA4 LINC02694	2.45e-03	477	113	7	C0005586
Disease	urinary microalbumin measurement	MON2 GDA	2.64e-03	20	113	2	EFO_0010967
Disease	disease of metabolism (implicated_via_orthology)	PFKL PFKM	2.91e-03	21	113	2	DOID:0014667 (implicated_via_orthology)
Disease	Non-Small Cell Lung Carcinoma	MXRA5 CASP8 E2F3 MAP2K2	3.10e-03	156	113	4	C0007131
Disease	Graves disease	TG FCRL3 CTLA4	3.76e-03	81	113	3	EFO_0004237
Disease	Alcoholic Intoxication, Chronic	TIPARP PHF3 TESK2 ASTN1 LINC02694	3.77e-03	268	113	5	C0001973
Disease	stomach carcinoma (is_marker_for)	SLC3A2 KMT2C	3.80e-03	24	113	2	DOID:5517 (is_marker_for)

Protein segments in the cluster

Peptide	Gene	Start	Entry
INGTCIVNESMLTGE	ATP13A3	311	Q9H7F0
CADGLLGEEQMIEQV	ARHGEF5	251	Q12774
LMEDSDGNCEGSSLV	BNC1	886	Q01954
CADGLLGEEQMIEQV	ARHGEF35	251	A5YM69
DDEATLNGMGLVIAQ	ARMH3	236	Q5T2E6
LDAACGIDKTENGNM	ANKRD36	441	A6QL64
GNESLLDNCQMTVLG	CD163L1	971	Q9NR16
GLQGACLMETVELLQ	DCTN2	251	Q13561
GDETGVMDNLLEALQ	DIAPH3	1056	Q9NSV4
GCNVNDRDGLTDMTL	CLIP4	96	Q8N3C7
QCDVIVAGGVELMSD	HADHB	156	P55084
SMTQEEFVEAAGLCG	ELF5	101	Q9UKW6
LCNGKLQAMSGEEVD	ATP2C2	616	O75185
TLDSLQGCNEKSGMD	ASTN1	271	O14525
RDTGQCMASLQEISG	NWD2	1261	Q9ULI1
CDFGVSGQLIDSMAN	MAP2K2	211	P36507
VQGEICLSVQMLEDG	RASAL1	116	O95294
LEDQSSKAGDMGNCV	RFTN1	481	Q14699
MAFSAEQDLQLCVGG	HJV	306	Q6ZVN8
IQVSNILGMDFCGID	RIMKLA	246	Q8IXN7
TTIAMTLGNDLQRCG	INTS7	651	Q9NVH2
QENGIEICMDFLQGT	TIPARP	236	Q7Z3E1
CTMEVEGGEKLQTDQ	CADPS	421	Q9ULU8
SLITIEDNGCQMSDA	NUP133	371	Q8WUM0
DLDSGANGQVTCSLM	PCDHA8	376	Q9Y5H6
EEESGMSDQLCGIAA	KIAA0100	1551	Q14667
GTINMNQCTDVVDGE	MPRIP	96	Q6WCQ1
GVCLTESGMTQLQSL	KMT2C	1176	Q8NEZ4
EMEAQLSQALEELGG	MAD1L1	451	Q9Y6D9
LDLTCEGSLSDEQGM	MAGEC3	256	Q8TD91
GLEACAMSLDTQETQ	IL17REL	41	Q6ZVW7
SLVDAMNGKEGVVEC	MDH2	261	P40926
GEICEMQTEELAGNS	PCM1	1996	Q15154
LVGSIDNDFCGTDMT	PFKL	161	P17858
LVGSIDNDFCGTDMT	PFKM	161	P08237
TMIVADGQSICGELS	PEAK1	76	Q9H792
ELGGICSISQVEEEM	NEK4	396	P51957
ITLCTGDELTLMGQA	GAREM1	146	Q9H706
DCEEGFELMGAQSLQ	SELE	271	P16581
LCSDEDLQSIQMQLG	ANKS4B	376	Q8N8V4
ELSTCENGSLNMEIN	PLEKHA8	216	Q96JA3
SMIEGELGELETECQ	MON2	501	Q7Z3U7
GNITLMEKCDVTDLG	PCDH11X	731	Q9BZA7
NTKVMLISDIDGDGC	ITFG2	126	Q969R8
EALMSIFQEEGGLCS	NDOR1	561	Q9UHB4
DLSGNQLEDEGCRLM	NLRC5	876	Q86WI3
GMTKAENGTCIDIDE	HMCN1	5261	Q96RW7
TCQGNLLIMGTEDAS	NUTM1	861	Q86Y26
QDLTQDGLMDLAVGA	ITGAD	591	Q13349
CELQIRGLAMADTGE	OBSCN	3591	Q5VST9
LDQDSGDNGRMICSI	PCDHB14	371	Q9Y5E9
GECMVNESSLTGESI	ATP13A2	336	Q9NQ11
GNTELTGQEELMEIS	FAM126A	331	Q9BYI3
ESLQTCEQNEMLSIG	HYDIN	1311	Q4G0P3
SLVVLGSAMELCGND	SLC2A11	276	Q9BYW1
GMLAQCQGLSKEVTE	E2F3	251	O00716
RGMELQGCASTQVES	CCDC34	111	Q96HJ3
GQGSICSQAIMLITD	CACNA2D3	356	Q8IZS8
GGLKLSQDMDTCEDI	GAS6	266	Q14393
DCGQMQEELDLTISA	C5	1531	P01031
MASDSGNQGTLCTLE	CCS	1	O14618
EMIETGSDCVTQAGL	SLC3A2	66	P08195
FSNGEELCGVMTISD	CASP8	196	Q14790
RDSCQQGSNMTLIGE	LTBP3	81	Q9NS15
GGQLIEGENMVLICS	FCRL3	296	Q96P31
EGENMVLICSVAQGS	FCRL3	301	Q96P31
LSCSETLMGELGNIA	GDA	216	Q9Y2T3
ESCDKGIEVNLLGSM	KANK4	426	Q5T7N3
EQVMTSTGNQALCGE	KLF18	656	A0A0U1RQI7
MGNELTFLDDSICTG	CTLA4	91	P16410
MAAILDDQTVCGRGE	GRIK5	26	Q16478
QTLDLEDCGIMDSQL	PRAMEF8	351	Q5VWM4
MLVQAGANIDTCSED	EHMT1	791	Q9H9B1
SFELENVCGMIQSSG	MEP1B	266	Q16820
LSTCENGSLNMEING	PLEKHA8P1	101	O95397
SLLEDAIGCMEANQG	RBM6	506	P78332
SGADINSICQESGML	PSMC4	371	P43686
VLQESMGGDDILLAC	TBC1D21	286	Q8IYX1
NNMETLIECQSEGDI	TAGAP	16	Q8N103
SLQDMSCQLLVNAEG	SYNE1	8611	Q8NF91
MADLGLTECCGNSNL	PLEKHG4	976	Q58EX7
GKMLETCGDAENQLA	ARHGAP17	91	Q68EM7
MGLDISSDGQLIATC	PRPF4	496	O43172
MGDILCNDGSLLLQD	JAML	91	Q86YT9
GDLIQAINGESTELM	PDLIM4	46	P50479
DDTAVLVIDNGSGMC	POTEJ	666	P0CG39
ITDKCNMINGTDGDS	SCARB2	241	Q14108
MLCGDNLDNDGDGLT	TENM1	801	Q9UKZ4
CSGNMGLLQQLEADI	WRN	646	Q14191
QNEEGMVGELIAFCT	POLA2	36	Q14181
VCRGLEESLGMVAQA	OVCA2	91	Q8WZ82
VQSGCGEINDSLMEL	PRPS1L1	56	P21108
QCLMEGSAILGDDTL	ARHGAP44	76	Q17R89
SQQLDGLLGMLCVDV	SESTD1	391	Q86VW0
SCQEEMISLGDGDIR	NCAPH	401	Q15003
VNVRFCLEGMEESGS	CNDP2	156	Q96KP4
MELQGAQEDLGISLS	LINC02694	1	Q8NAA6
NVCEMNGIAETSLLE	NLRP9	186	Q7RTR0
QTLDLEDCGIMDSQL	PRAMEF7	351	Q5VXH5
REETLQTMVLGCQAG	nan	491	Q6ZTK2
DMLTAAQGGICLALD	ERVFRD-1	421	P60508
QGMLSVAEELCQEST	RMND5B	131	Q96G75
GCLDSVMENSKVLGE	TLN1	1391	Q9Y490
GSCMVEESGTLESQL	SPTAN1	2231	Q13813
IQSGCGEINDNLMEL	PRPS2	56	P11908
CVGLSLSQAQQMGEE	PHF3	746	Q92576
GQMTEDNIEVGICNE	PSMA2	201	P25787
QVSNILGMDVCGIDL	RIMKLB	251	Q9ULI2
VQSGCGEINDNLMEL	PRPS1	56	P60891
NSTSGECLLLEAEGM	ZFP91	501	Q96JP5
NMLAEIFCQTGGVED	ZBED1	546	O96006
SLDNMIGQSAIAGEE	WDR11	426	Q9BZH6
LNTLQCSESIMGGAV	POSTN	306	Q15063
EAMDCSILQEENGFG	TESK2	511	Q96S53
VCMTINGLETAEGLD	TUT7	1061	Q5VYS8
TMNGCSVEDLGLDFT	TRIP12	1781	Q14669
ILLTSCTEENGMDQE	UBR2	1456	Q8IWV8
TLNSLGIQMCSEENG	TG	2026	P01266
QMTGLQCSSALGALD	nan	71	Q499Y3
CDAGNRALELSGVME	UNC45A	426	Q9H3U1
VFDEIVENCGGIMDT	ZMYM4	21	Q5VZL5
CQGSTMELLQDVSDV	TRIM6	241	Q9C030
SDSVQLVCMARNEGG	MXRA5	2511	Q9NR99